104 related articles for article (PubMed ID: 2138243)
21. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
Gui K
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
[TBL] [Abstract][Full Text] [Related]
22. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
24. [Localization of oncoprotein P21ras in the human liver cancer].
Hong JX; Wei MH; Zhang X; Liu YW; Wan DF; Gu JR; Yu XS; Shi DR; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):81-4. PubMed ID: 3308383
[TBL] [Abstract][Full Text] [Related]
25. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
Going JJ; Williams AR; Wyllie AH; Anderson TJ; Piris J
J Pathol; 1988 Jul; 155(3):185-90. PubMed ID: 3045276
[TBL] [Abstract][Full Text] [Related]
26. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
[TBL] [Abstract][Full Text] [Related]
27. The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas.
Hong L; Han Y; Li S; Yang J; Zheng J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2010 Dec; 10(12):1693-701. PubMed ID: 20977295
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
Matarazzo M; Faraggiana T; Donato MF; Paronetto F
J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467
[TBL] [Abstract][Full Text] [Related]
29. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
30. Activation of Raf-1 in human pancreatic adenocarcinoma.
Berger DH; Jardines LA; Chang H; Ruggeri B
J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
Dang CX; Han Y; Qin ZY; Wang YJ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
[TBL] [Abstract][Full Text] [Related]
32. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
33. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
35. [Oncogenes in human gastric carcinoma].
Tahara E
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
[TBL] [Abstract][Full Text] [Related]
36. [Study on the expression of oncogene mRNA in hepatocellular carcinoma using in situ hybridization technique].
Hayashi D
Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):814-22. PubMed ID: 7830708
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
[TBL] [Abstract][Full Text] [Related]
38. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
39. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
[TBL] [Abstract][Full Text] [Related]
40. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]